Financhill
Sell
45

STRO Quote, Financials, Valuation and Earnings

Last price:
$1.07
Seasonality move :
-5.87%
Day range:
$0.92 - $1.07
52-week range:
$0.52 - $5.17
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.32x
P/B ratio:
2.01x
Volume:
1.6M
Avg. volume:
2M
1-year change:
-71.39%
Market cap:
$89.6M
Revenue:
$62M
EPS (TTM):
-$3.02

Earnings Data

Next earnings date for STRO
May 13
2025
Most recent earnings per share
-$0.89
Beat by $0.07
(Mar 13/2025)
Consensus Estimate
-$0.96
(Mar 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

STRO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $11.5M -- -- -- --
05/13/2025 Q1 $11.6M -- -- -- --
03/13/2025 Q4 $12.2M $14.8M -$0.89 -$0.96 $0.07
11/13/2024 Q3 $15.3M $8.5M -$0.59 -$0.74 $0.15
08/13/2024 Q2 $21M $25.7M -$0.59 -$0.90 $0.31
05/13/2024 Q1 $12.1M $13M -$0.95 -$1.00 $0.05
03/25/2024 Q4 $13.2M $113.7M $0.52 -$0.84 $1.36
11/13/2023 Q3 -- -- -$0.81 -$0.72 -$0.09
08/10/2023 Q2 -- -- -$0.64 -$0.69 $0.05
05/15/2023 Q1 -- -- -$0.85 -$0.75 -$0.10
03/30/2023 Q4 -- -- -$0.61 -$0.63 $0.02
11/08/2022 Q3 -- -- -$0.37 $0.01 -$0.38
08/08/2022 Q2 -- -- -$0.55 -$0.77 $0.22
05/09/2022 Q1 -- -- -$0.84 -$0.74 -$0.10
02/28/2022 Q4 -- -- -$0.83 -$0.76 -$0.07
11/10/2021 Q3 -- -- -$0.67 -$0.48 -$0.19
08/09/2021 Q2 -- -- -$0.13 -$0.40 $0.27
05/07/2021 Q1 -- -- -$0.66 -$0.60 -$0.06
03/18/2021 Q4 -- -- -$1.90 -$0.48 -$1.42
11/05/2020 Q3 -- -- $0.45 -$0.50 $0.95
08/06/2020 Q2 -- -- $0.94 -$0.57 $1.51
05/11/2020 Q1 -- -- -$0.84 -$0.57 -$0.27
03/16/2020 Q4 -- -- -$0.64 -$0.66 $0.02
11/08/2019 Q3 -- -- -$0.56 -$0.62 $0.06
08/14/2019 Q2 -- -- -$0.60 -$0.60 $0.00
04/01/2019 Q1 -- -- -$0.62 -$0.61 -$0.01
12/31/2018 Q4 -- -- -$0.07 -$0.67 $0.60
11/14/2018 Q3 -- -- -$0.43 $1.97 -$2.40

Sutro Biopharma Earnings Questions

  • How Much did Sutro Biopharma Generate in Revenue Last Quarter?

    Sutro Biopharma reported $14.8M worth of top line sales in its most recent quarter.

  • Did Sutro Biopharma Beat Earnings Last Quarter?

    Sutro Biopharma announced earnings per share of -$0.89 which represents a beat of analyst forecast a -$0.96 per share.

  • Is Sutro Biopharma Profitable?

    Sutro Biopharma reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Sutro Biopharma EPS Next Year?

    Sutro Biopharma's earnings are forecast to decrease from -$2.96 per share to -$3.07 per share next year representing a decrease of -16.22%.

  • When is Sutro Biopharma's Earnings Date?

    Sutro Biopharma's next earnings date is May 13, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Palantir Stock a Millionaire Maker?
Is Palantir Stock a Millionaire Maker?

Palantir (NASDAQ:PLTR) has shot upward over the last year and…

Is QuantumScape a Buy Now?
Is QuantumScape a Buy Now?

QuantumScape (NYSE:QS) is an innovative EV battery company that specializes…

Is Vertex Stock Still a Good Buy?
Is Vertex Stock Still a Good Buy?

Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…

Stock Ideas

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Buy
59
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 38x

Alerts

Buy
62
RGC alert for May 2

Regencell Bioscience Holdings [RGC] is down 15.58% over the past day.

Sell
36
WGS alert for May 2

GeneDx Holdings [WGS] is up 0.29% over the past day.

Sell
42
VICR alert for May 2

Vicor [VICR] is up 2.51% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock